A detailed history of Fort Pitt Capital Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fort Pitt Capital Group, LLC holds 1,387 shares of LLY stock, worth $1.04 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,387
Previous 1,307 6.12%
Holding current value
$1.04 Million
Previous $1.18 Million 3.8%
% of portfolio
0.03%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$772.14 - $960.02 $61,771 - $76,801
80 Added 6.12%
1,387 $1.23 Million
Q2 2024

Jul 26, 2024

BUY
$724.87 - $909.04 $112,354 - $140,901
155 Added 13.45%
1,307 $1.18 Million
Q1 2024

Apr 11, 2024

SELL
$592.2 - $792.28 $18,950 - $25,352
-32 Reduced 2.7%
1,152 $896,000
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $64,598 - $76,152
123 Added 11.59%
1,184 $690,000
Q3 2023

Nov 07, 2023

BUY
$434.7 - $599.3 $116,934 - $161,211
269 Added 33.96%
1,061 $569,000
Q2 2023

Jul 28, 2023

SELL
$350.74 - $468.98 $21,044 - $28,138
-60 Reduced 7.04%
792 $371,000
Q1 2023

May 16, 2023

BUY
$310.63 - $364.82 $264,656 - $310,826
852 New
852 $292,000
Q1 2021

Apr 16, 2021

SELL
$164.32 - $212.72 $103,357 - $133,800
-629 Closed
0 $0
Q4 2020

Feb 23, 2021

SELL
$130.46 - $172.63 $208,736 - $276,208
-1,600 Reduced 71.78%
629 $106,000
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $18,862 - $21,817
-129 Reduced 5.47%
2,229 $330,000
Q2 2020

Aug 12, 2020

SELL
$136.42 - $164.18 $26,056 - $31,358
-191 Reduced 7.49%
2,358 $387,000
Q1 2020

May 15, 2020

BUY
$119.05 - $147.35 $45,000 - $55,698
378 Added 17.41%
2,549 $354,000
Q4 2019

Feb 18, 2020

BUY
$106.92 - $132.43 $29,189 - $36,153
273 Added 14.38%
2,171 $285,000
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $202,687 - $220,471
1,898 New
1,898 $212,000
Q2 2019

Aug 09, 2019

SELL
$110.79 - $129.32 $210,057 - $245,190
-1,896 Closed
0 $0
Q1 2019

May 09, 2019

BUY
$111.31 - $131.02 $1,669 - $1,965
15 Added 0.8%
1,896 $246,000
Q4 2018

Feb 06, 2019

SELL
$105.9 - $118.64 $196,868 - $220,551
-1,859 Reduced 49.71%
1,881 $218,000
Q2 2018

Aug 09, 2018

BUY
$75.7 - $86.88 $3,028 - $3,475
40 Added 1.08%
3,740 $319,000
Q1 2018

May 14, 2018

BUY
$74.21 - $87.6 $274,577 - $324,120
3,700 New
3,700 $286,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fort Pitt Capital Group, LLC Portfolio

Follow Fort Pitt Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Pitt Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Pitt Capital Group, LLC with notifications on news.